Abstract
Blocking a protein known as EPAC1 may prevent the development of heart-related side effects caused by a chemotherapy drug.
Original language | English |
---|---|
Article number | e91831 |
Number of pages | 3 |
Journal | eLife |
Volume | 12 |
DOIs | |
Publication status | Published - 6 Sept 2023 |
Keywords
- cancer biology
- cancer survivorship
- cardiotoxicity
- cell biology
- doxorubicin
- EPAC1
- human
- mouse
- rat